DioGenix

DioGenix, Inc. is a molecular diagnostics company developing and commercializing non-invasive diagnostic, prognostic and treatment response monitoring tests for neurological diseases and disorders. The company's lead product, MSPrecise®, is designed to improve the information available to neurologists when facing non-specific neurological dysfunction where multiple sclerosis (MS) is suspected. This program will, for the first time, provide neurologists with a comprehensive set of next-generation sequencing assays to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment.

To learn more about DioGenix, please visit: www.DioGenix.com. 

Fast Forward, a subsidiary of the National MS Society, is funding research conducted by DioGenix to determine if the same approach used for MSPrecise® testing cerebral spinal fluid will work with blood samples. To learn more about Fast Forward, please visit: http://www.nationalmssociety.org/fast-